The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...
The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback